Searched for
MOREPEN LABS EARNINGS
Here's why Mayuresh Joshi is bullish on Morepen LabsSo, to that extent, there is some element of stickiness that comes through in numbers. But one must also understand both in terms of their ...- Mayuresh Joshi on his 2 top bets in pharma & what he likes in oil & gas sectorMayuresh Joshi from Marketsmith India shared insights on favored pharma stocks like Natco, Morepen, Cipla, and Dr Reddy's, emphasizing stro...
- Ahead of Market: 10 things that will decide D-Street action on WednesdayMomentum indicator Moving Average Convergence Divergence (MACD) showed a bullish trade setup on the counters of Axis Bank, Morepen Labs, M&...
- Market Movers: Investors dump Nykaa shares ahead of earningsNykaa has faced massive selloff off late as Street dumped shares of richly valued new-age companies against the backdrop of Fed rate hikes,...
- Morepen Laboratories Q3 Results: Profit dips 10% to Rs 22 crNet revenue, however, rose to Rs 399.19 crore in the third quarter as compared with Rs 310.26 crore in the same period of 2020-21, Morepen ...
- Ahead of Market: 12 things that will decide stock action on ThursdayThe 18,100 level for Nifty50 would be the key to watch out for
- Ahead of Market: 12 things that will decide stock action on FridayGaurav Ratnaparkhi, Head of Technical Research, Sharekhan by BNP Paribas said With Thursday's bounce the Nifty50 has once again tested the ...
- 125% jump in a month, 360% in a year; safety rush turns this laggard a multibaggerThe smallcap pharma scrip has been thumping rock and roll over the past few weeks.
- Sensex ends volatile day 32 pts higher as D-St clocks longest winning streak since early FebConfirmed Covid-19 cases in India rose above 18 million with a record rise in infections and deaths over the last 24 hours.
- Stocks in news: Reliance Inds, Hindustan Unilever, Titan, Bajaj Auto and Ambuja CementsHindustan Unilever, Titan and Bajaj Auto, Ambuja Cements, Motherson Sumi, Bajaj Holdings, Shriram Transport, AU SFB, IndiaMart InterMesh an...
- Midcap pharma regains its vigour on Dalal StreetSo far this week, Nectar Life has gained 36 per cent, Morepen has risen 30 per cent, Panacea has moved up 28 per cent Suven Life has advanc...
- Ahead of Market: 12 things that will decide stock action on Thursday“We maintain our cautious stance for the markets in the near term as increasing restriction would adversely impact economic activities,” sa...
- Morepen Labs Q4 results: Net profit rises 5% to Rs 11 croreIts consolidated total revenue stood at Rs 208.38 crore for the quarter under consideration.
- YES Bank, KRBL among 24 stocks that have rallied over 100% from March lowsCompany as well as sector-specific developments mainly drove a couple of stocks.
- Is your portfolio anaemic? Careful, the pharma pill may not help defend against vulnerabilityBrokerages turned cautious on the sector just ahead of September quarter earnings.
- Pharma stocks for defensive bias or to gain from weak rupee? Must read thisNifty Pharma index outpaced the benchmark index which slipped more than 1 per cent.
- VIP, Adani Green Energy, Kwality and ONGC among top stocks to track todayHere's a look at the top stocks that are likely to hog limelight in today's trading session.
- Stock market update: Market trades higher; Shriram EPC, Biocon surgeThe Sensex rallied over 340 points, and Nifty breached the 11,200 mark for the first time today.
- Pharma stocks lose Rs 50,000 cr in m-cap in 2016; 3 buy ideas from global brokeragesBSE Healthcare index was one of the biggest laggards of 2016, with many stocks losing over 40% during the period, including Orchid Chemical...
- Talking stock: Hindalco fairly priced, move to CILEvery week, an expert selected by ET answers queries from our readers on stocks
Load More
